Stock Price Quote

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE1517.203.1 (+0.2 %)
PREV CLOSE ( ) 1514.10
OPEN PRICE ( ) 1542.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 6082
TODAY'S LOW / HIGH ( )1504.80 1560.00
52 WK LOW / HIGH ( )1433.05 1917
NSE1520.755.85 (+0.39 %)
PREV CLOSE( ) 1514.90
OPEN PRICE ( ) 1549.00
BID PRICE (QTY) 1520.75 (43)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 107901
TODAY'S LOW / HIGH( ) 1508.45 1550.00
52 WK LOW / HIGH ( )1449 1918.75
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 13-11 1924
Management Info
R S Karnad - Chairman S Venkatesh - Managing Director
Registered Office

Address Dr Annie Besant Road,Worli,,
Mumbai,
Maharashtra-400030

Phone 022-24959595

Email in.investorquery@gsk.com

Website www.gsk-india.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

17May Glaxosmithkline Pharmaceuticals trades
Glaxosmithkline Pharmaceuticals is currently trading at Rs. 1518.75, up..
17May Glaxosmithkline Pharmaceuticals report
Glaxosmithkline Pharmaceuticals has reported results for fourth quarter..
02May Board Meeting Intimation for Audited
GLAXOSMITHKLINE PHARMACEUTICALS LTD.has informed BSE that the meeting of..
27Apr GlaxoSmithKline Pharmaceuticals inches
Glaxosmithkline Pharmaceuticals is currently trading at Rs. 1593.65, up..
26Apr GlaxoSmithKline Pharmaceuticals launch
GlaxoSmithKline Pharmaceuticals has launched Trelegy Ellipta for Chronic..

Financials

in Millions
QTR Mar 22 ANNUAL 22
Net Profit12178.416905.3
Gross Profit 2062.4 7734.5
Operating Profit 1923.68320.5
Net Sales 7919.232175.1

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  17635.70 (6.69%)
M.Cap ( in Cr)37474.63
Procter&Gamble Healt (BSE)
peergroup  4518.60 (4.03%)
M.Cap ( in Cr)7500.60
Piramal Enterprises (BSE)
peergroup  1983.75 (5.80%)
M.Cap ( in Cr)47344.91
Astrazeneca Pharma I (BSE)
peergroup  2576.60 (3.41%)
M.Cap ( in Cr)6441.50
Divi's Lab (BSE)
peergroup  4302.25 (1.96%)
M.Cap ( in Cr)114211.22

Shareholding Pattern

PROMOTERS 75%
MUTUAL FUNDS/UTI 4.17%
NON-INSTITUTION 12.09%
FI/BANKS/INSURANCE 1.44%
FII 0%
GOVERNMENT 0%

About Glaxosmithkline Pharmaceuticals Ltd.

Glaxosmithkline Pharmaceuticals Ltd. was incorporated in the year 1924. Its today's share price is 1517.2. Its current market capitalisation stands at Rs 25702.28 Cr. In the latest quarter, company has reported Gross Sales of Rs. 31937.36 Cr and Total Income of Rs.33039.24 Cr. The company's management includes Juby Chandy, Mark Dawson, Ajay Nadkarni, S Williams, D Sundaram, A N Roy, S Maheshwari, N Kaviratne ( C B E ), PV Bhide, S Venkatesh, R S Karnad.

It is listed on the BSE with a BSE Code of 500660 , NSE with an NSE Symbol of GLAXO and ISIN of INE159A01016. It's Registered office is at Dr Annie Besant Road,Worli,Mumbai-400030, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Deloitte Haskins & Sells LLP, Lovelock & Lewes, Price Waterhouse & Co, Price Waterhouse & Co Bangalore LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)